Kendra Adams
Financieel Directeur/CFO bij C4 THERAPEUTICS, INC.
Vermogen: 511 923 $ op 30-04-2024
Actieve functies van Kendra Adams
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
C4 THERAPEUTICS, INC. | Financieel Directeur/CFO | 18-09-2023 | - |
Treasurer | 18-09-2023 | - | |
Investor Relations Contact | 20-11-2020 | 18-09-2023 | |
Public Communications Contact | 20-11-2020 | 18-09-2023 |
Loopbaan van Kendra Adams
Eerdere bekende functies van Kendra Adams
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AGIOS PHARMACEUTICALS, INC. | Investor Relations Contact | - | - |
Public Communications Contact | - | - | |
ARIAD PHARMACEUTICALS, INC. | Investor Relations Contact | - | - |
Opleiding van Kendra Adams
Hamilton College (New York) | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Investor Relations Contact | 3 |
Public Communications Contact | 2 |
Director of Finance/CFO | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
AGIOS PHARMACEUTICALS, INC. | Health Technology |
C4 THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Kendra Adams
- Ervaring